The Journal of Advanced Biotechnology and Experimental Therapeutics (JABET) is an international, open-access, and peer-reviewed scientific journal. It provides a global platform for scientists and academicians to share and discuss new discoveries in translational research, biotechnology, and biomedical sciences. The journal specifically encourages submissions featuring rigorous quantitative analyses, cellular studies, and new insights into biochemical mechanisms across human, animal, and medicinal plant subjects.

JABET covers a wide range of specialized topics within its scientific scope. These include molecular biology, bioinformatics, microbiology, nano-bioscience, metabolism, and diseases. Additionally, the journal focuses on research fields such as physiology, immunology, plant medicine, pharmacology, stem cells, cancer biology, reproductive and aquatic biology, as well as toxicants and human health.

The primary vision of the journal is to raise awareness of modern breakthroughs among experts and young scientists while accelerating publication through a rapid peer-review process. By disseminating high-quality research data to the global health community, JABET aims to meet the growing demand for vital biotechnological information. Ultimately, the journal supports the free exchange of scientific knowledge to help improve the overall livelihood of the global population.

Research Area: Biochemistry, Genetics & Molecular Biology; Immunology & Microbiology; Pharmacology, Toxicology & Pharmaceutics; Medicine; Biology